Fir Tree Capital Management’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-65,465
Closed -$5K 696
2022
Q2
$5K Sell
65,465
-1,200
-2% -$208 ﹤0.01% 712
2022
Q1
$13K Hold
66,665
﹤0.01% 723
2021
Q4
$39K Hold
66,665
﹤0.01% 696
2021
Q3
$42K Hold
66,665
﹤0.01% 548
2021
Q2
$74K Hold
66,665
﹤0.01% 507
2021
Q1
$60K Buy
+66,665
New +$113K ﹤0.01% 414

Other funds holding FLACW

Fir Tree Capital Management's FLACW Position: Q3 2022 in Review

Fir Tree Capital Management sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q3 2022, closing a stake of 65,465 shares — an estimated $5K sold.

Fir Tree Capital Management first reported a position in FLACW in Q1 2021 and held it in 6 quarters. The position peaked at $74K in Q2 2021. 21 funds tracked by Wall St. Rank hold FLACW as of Q3 2022.

  • Fir Tree Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
  • Fir Tree Capital Management sold 65,465 Frazier Lifesciences Acquisition Corporation Warrant shares in Q3 2022, an estimated $5K.
  • Fir Tree Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 6 quarters.
  • Fir Tree Capital Management's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $74K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q3 2022.

Based on Fir Tree Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.